A study revealed that treatment with oxaliplatin can increase the PD-L1+ tumor-infiltrating B-cells, inducing CD8+ T-cell exhaustion and chemotherapy resistance [95]; another research correlated the resistance to radiotherapy with the increased expression of PD-1 in infiltrating CD45+/CD8+ T-cells [106]. This evidence concerns the gene PTPRC and neoplasm.